Cancer survivors in the United States who report diminished quality of life "more than doubled" in the past two decades, according to a study published May 11 in JAMA Oncology.
The Latest
Tampa-based Moffitt Cancer Center appointed Xavier Avat as chief business officer, the Business Observer reported June 5.
Continuing immunotherapy treatments when a renal cancer patient's disease has progressed may actually do more harm than good, according to results of a new study from Los Angeles-based City of Hope researchers.
Some patients with locally advanced rectal cancer may be able to safely forgo radiation before surgery to remove tumors, according to research published June 4 in The New England Journal of Medicine and the Journal of Clinical Oncology.
Grail, a company that developed blood tests to detect cancer, mistakenly sent approximately 400 customers letters saying they might be positive for the disease, The New York Times reported June 4.
GenesisCare, a global cancer and cardiac care service provider, has filed for Chapter 11 bankruptcy, according to a June 1 press release.
Here are the 10 most-read oncology stories published by Becker's in May:
Some immunotherapies and small molecule kinase inhibitors have been shown to cause "major fungal infections," according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.
Some immunotherapies and small molecule kinase inhibitors have been shown to cause "major fungal infections," according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.
Screenings that were delayed due to COVID-19 are likely to contribute to an exponential increase in cancer diagnosis totals over the next few years, experts say.